Fermentalg

Fermentalg

ALGAE.PAPre-clinical
Libourne, FranceFounded 2009fermentalg.com

Fermentalg is a pioneer in microalgae biotechnology, utilizing its proprietary fermentation platform to produce sustainable, high-value ingredients for the nutrition, health, and cosmetics markets. The company's core strength lies in its extensive library of microalgae strains and its ability to scale production through industrial fermentation, offering a more reliable and sustainable alternative to traditional algae cultivation. As a public company, it aims to address global challenges in food security and sustainable sourcing through its innovative, nature-derived products.

Market Cap
$395.4M
Founded
2009
Employees
50-100
Focus
Biotech

ALGAE.PA · Stock Price

USD 3.575.37 (-60.06%)

Historical price data

AI Company Overview

Fermentalg is a pioneer in microalgae biotechnology, utilizing its proprietary fermentation platform to produce sustainable, high-value ingredients for the nutrition, health, and cosmetics markets. The company's core strength lies in its extensive library of microalgae strains and its ability to scale production through industrial fermentation, offering a more reliable and sustainable alternative to traditional algae cultivation. As a public company, it aims to address global challenges in food security and sustainable sourcing through its innovative, nature-derived products.

Technology Platform

Proprietary fermentation platform using a vast library of microalgae strains to produce high-value ingredients (lipids, proteins, pigments) in controlled bioreactors, offering a sustainable and scalable alternative to traditional cultivation.

Opportunities

Significant growth is driven by the global demand for sustainable, natural ingredients in nutrition and cosmetics.
Key opportunities include capturing market share in the algal omega-3 sector as an alternative to fish oil, expanding into the high-growth plant-based protein market, and developing novel active ingredients for the green cosmetics industry.

Risk Factors

Key risks include the technical and financial challenges of industrial scale-up, intense competition from larger, established ingredient companies, the lengthy and uncertain regulatory approval process for novel food ingredients, and the company's ongoing dependence on external funding to achieve profitability.

Competitive Landscape

Fermentalg competes with large fermentation-based producers like DSM and Corbion, traditional algae cultivators, and synthetic biology companies. Its differentiation is based on its proprietary microalgae strain library, its fully integrated fermentation platform, and its focus on producing a diverse portfolio of sustainable ingredients for specialized applications.

Company Info

TypePlatform
Founded2009
Employees50-100
LocationLibourne, France
StagePre-clinical
RevenueEarly Revenue

Trading

TickerALGAE.PA
ExchangeEPA

Therapeutic Areas

NutritionCosmetics
SIMILAR COMPANIES
4P-Pharma
4P-Pharma
Phase 2 · Lille
Patheon
Patheon
Pre-clinical · Lyon
ABL Diagnostics
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Adjuvatis
Pre-clinical · Lyon
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile